Get started
Author

Lillian Van De Verg

Observed names: L Van De Verg, L Van de Verg, L. Van De Verg, LILLIAN VAN DE VERG, Lillian Van de Verg, Lillian van de Verg
OpenAlex ID: A5090339584
Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease
1990 · Deirdre A. Herrington, Lillian Van De Verg, et al. · Vaccine · 146
Deletion of purE attenuates Brucella melitensis infection in mice
1996 · R M Crawford, L Van De Verg, et al. · Infection and Immunity · 102
Experimental Gonococcal Urethritis and Reinfection with Homologous Gonococci in Male Volunteers
2001 · KATHERINE A. SCHMIDT, HERMAN SCHNEIDER, et al. · Sexually Transmitted Diseases · 90
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen
1992 · K L Kotloff, D A Herrington, et al. · Infection and Immunity · 76
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei
1990 · L Van de Verg, D A Herrington, et al. · Infection and Immunity · 74
Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli
2013 · Samer S. El-Kamary, Mitchell B. Cohen, et al. · Clinical and Vaccine Immunology · 63
Intradermal Delivery of Shigella IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes
2014 · Shannon J Heine, Jovita Diaz-McNair, et al. · The Journal of Immunology · 55
Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects
2016 · Subhra Chakraborty, Clayton Harro, et al. · Clinical and Vaccine Immunology · 50
Sialylation Lessens the Infectivity of Neisseria gonorrhoeae MS11mkC
1996 · H. Schneider, K. A. Schmidt, et al. · The Journal of Infectious Diseases · 50
Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection
1996 · L Van De Verg · Vaccine · 40
Protection of Mice against Brucellosis by Intranasal Immunization withBrucella melitensisLipopolysaccharide as a Noncovalent Complex withNeisseria meningitidisGroup B Outer Membrane Protein
2002 · Apurba K. Bhattacharjee, Lillian Van De Verg, et al. · Infection and Immunity · 32
Characteristics of Shigella sonnei Infection of Volunteers: Signs, Symptoms, Immune Responses, Changes in Selected Cytokines and Acute-Phase Substances
1995 · Carlos Munoz, Shahida Baqar, et al. · American Journal of Tropical Medicine and Hygiene · 30
Vaccines for enteric diseases: a meeting summary
2012 · Duncan Steele, Mark Riddle, et al. · Expert Review of Vaccines · 16
PDF
Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli
2014 · Samer S. El-Kamary, Mitchell B. Cohen, et al. · Clinical and Vaccine Immunology · 7
Potential for a Combined Oral Inactivated Whole-Cell Vaccine Against ETEC and Shigella: Preclinical Studies Supporting Feasibility
2025 · Manuela Terrinoni, Jan Holmgren, et al. · Vaccines · 4
PDF
Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model
1992 · Thomas Larry Hale, Corey P. Mallett, et al. · Vaccine · 3
Safety, immunogenicity, and efficacy in man of an invasive Escherichia coli K-12 hybrid vaccine expressing Shigella flexneri 2a somatic antigen
1992 · K. Kotloff, D. Herrington, et al. · Vaccine · 1
Evaluation of the Safety, Tolerability and Immunogenicity of an Oral, Inactivated Whole
2016 · Subhra Chakraborty, Clayton Harro, et al.
Toxin (dmLT) Derived from Enterotoxigenic Escherichia coli (ETEC)
2013 · Samer S. El‐Kamary, Mitchell B. Cohen, et al.
Works count: 19
Citation count: 839
H-index: 13
I10-index: 13
Year
Topic
Type